Recombinant HCV NS4 a+b Rhodamine
Beta LifeScience
SKU/CAT #: BLIT-0828
Recombinant HCV NS4 a+b Rhodamine
Beta LifeScience
SKU/CAT #: BLIT-0828
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Tag | N/A |
Host Species | HCV |
Background | HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). |
Description | The E.coli derived 19 kDa recombinant protein rhodamine labeled contains the HCV NS4 immunodominant regions, amino acids 1658-1863. The protein is fused with b-galactosidase (114 kDa) at N-terminus. |
Source | E.coli |
Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
Formulation | 20mM Tris-Hcl pH 8, 8M urea and 10mM B-ME. |
Applications | Antibody ELISA; immunogen; WB, etc. |
Usage | For Research Use Only |